Pharmacy Tech Scholar
DECEMBER 20, 2021
PTCB Announces Medication Therapy Management Certificate Earlier this month, the Pharmacy Technician Certification Board (PTCB) announced the availability of the Medication Therapy Management (MTM) certificate for pharmacy… The post PTCB Announces New Medication Therapy Management Certificate appeared first on PharmacyTechScholar.com.
Outsourcing Pharma
DECEMBER 20, 2021
According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
DECEMBER 20, 2021
Oracle snags Cerner in $28B deal to gain a foothold in healthcare cloud market. hlandi. Mon, 12/20/2021 - 12:09.
Pharma Marketing Network
DECEMBER 20, 2021
R.J. Lewis, Founder and CEO of eHealthcare Solutions and Tap Native and the Chief Collaborator at Pharma Marketing Network, moderated a deep dive discussion on the topic of physician-level data (PLD) with a focus around drivers for the tool, its usage, and successes learnings about its function in pharma, and the where it’s heading. Guests of the panel included experts from GSK, Ispen, BioPharm Communications, and CMI, who all spoke to the importance of incorporating and leveraging PLD ins
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
DECEMBER 20, 2021
Industry Voices—Inside the most challenging data problem in healthcare. hlandi. Mon, 12/20/2021 - 15:28.
pharmaphorum
DECEMBER 20, 2021
Biogen has cut the list price of its Alzheimer’s disease therapy in half from $56,000 to $28,200 a year, before the outcome of an ongoing reimbursement review of the drug by the US government. The price reduction for Aduhelm (aducanumab) comes into play from 1 January and comes on the back of the “feedback of our stakeholders,” said the biotech’s chief executive Michel Vounatsos. “Too many patients are not being offered the choice of Aduhelm due to financial conside
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
DECEMBER 20, 2021
Continuing his Frontiers Health Digital Innovator’s series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. At Frontiers Health conference live in Milan , Sai discusses the history and broad reach of Aptar in the pharmaceutical space and its recent acquisition of Voluntis. Aptar continues to look for valuable partnerships to develop and expand its portfolio, and Sai relays the importance of synergies between digital health applications and Aptar
Fierce Healthcare
DECEMBER 20, 2021
'You can’t have healthy people on a sick planet': How healthcare is correcting its role in climate change. agliadkovskaya. Mon, 12/20/2021 - 23:09.
pharmaphorum
DECEMBER 20, 2021
Novartis’ big-selling IgE inhibitor Xolair has been a mainstay of treatment for chronic spontaneous urticaria (CSU) for many years, but with biosimilars looming the company has been looking to follow-up ligelizumab to defend the franchise. That hope now look decidedly faint, as ligelizumab was able to match Xolair (omalizumab) but not improve on it in a pair of phase 3 trials in CSU, although it did perform better than placebo.
Fierce Healthcare
DECEMBER 20, 2021
Drug price reforms, Medicaid coverage gap in balance after Manchin opposition to Build Back Better Act. rking. Mon, 12/20/2021 - 15:20.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
DECEMBER 20, 2021
Industry’s free pass to its target audience has been shredded by the pandemic leaving the sales force compass struggling to find effective routes. It has exposed a blind spot that was previously covered by engagement success rates and comfortable repeat business. Only now are we seeing the downside of a lack of finesse along the pathway from strategic sales conferences to client meetings.
Fierce Healthcare
DECEMBER 20, 2021
Goldman Sachs forecasts positive outlook for insurers in 2022, buoyed by shift to value-based care. hlandi. Mon, 12/20/2021 - 16:54.
pharmaphorum
DECEMBER 20, 2021
The FDA has approved AstraZeneca and Amgen’s severe asthma hope tezepelumab, exonerating the drugmakers’ decision to press ahead with a regulatory filing despite a failed phase 3 trial. Another phase 3 study supported the efficacy of the first-in-class TSLP inhibitor as an add-on treatment for people aged 12 and over with severe asthma, as did an earlier phase 2 trial, but the miss raised questions about the drug’s approvability.
Fierce Healthcare
DECEMBER 20, 2021
HHS preps for launch of 3-digit nationwide suicide prevention hotline by July. rking. Mon, 12/20/2021 - 11:56.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
DECEMBER 20, 2021
In a year already marked by big-ticket deals in the digital health arena, there may be even more to come, as reports circulate of a $30 billion offer looming for electronic health record (EHR) specialist Cerner by Oracle. The latest rumours seem to stem from a tweet from CNBC reporter David Faber yesterday, who said that the enterprise management software giant is poised to make an offer for Cerner in the mid-$90 range as early as today.
Outsourcing Pharma
DECEMBER 20, 2021
The pharmaceutical company has announced GMP-related challenges with a manufacturer contracted to fill syringes for Wegovy pens headed to the US market.
pharmaphorum
DECEMBER 20, 2021
Prof Gillian Leng’s replacement as chief executive of the National Institute for Health and Care Excellence (NICE) has been named as Dr Samantha Roberts, currently managing director for health and care at insurance group Legal and General. Roberts will take up the role on 1 February, as Leng retires from NICE after 20 years at the health technology assessment (HTA) agency.
Pharma Times
DECEMBER 20, 2021
It is estimated that chronic kidney disease affects more than 160 million people with type 2 diabetes worldwide.
Pharma Times
DECEMBER 20, 2021
Tetris Pharma’s Ogluo is the first ready-to-use, pre-mixed and pre-measured glucagon injection.
Expert insights. Personalized for you.
221 
Let's personalize your content